The altered metabolism of renal structural glycoproteins in insulin-dependent diabetes leads to the continuing accumulation of basement membrane-like material. This abnormality is evidenced by progressive thickening of the glomerular and tubular basement membrane (BM) and deposition of BM-like material in the glomerular mesangium [1, 2]. Contrary to previous prevailing belief, the abnormal metabolism of renal BM glycoproteins is an early event in diabetes. Glomerular BM mass is significantly increased 4 days after the induction of diabetes in rats [3]. Since glomerular BM has a turnover of 23 to 100 days [41, increased synthesis, rather than decreased breakdown, is a more likely explanation for the rapid accumulation of BM. In support of this concept, studies of aminoacid incorporation into glomerular BM in vivo have demonstrated an accelerated rate of polypeptide synthesis and proline hydroxylation after 9 days of diabetes [5]. Additional evidence for the increased synthesis of renal BM glycoproteins is derived from studies of the specific glycosyltransferases involved in the postribosomal glycosylation of newly formed BM peptides. The activity of collagen glucosyltransferase, the enzyme attaching glucose to hydroxylysine-linked galactose, is increased in the renal cortex of alloxan-induced or spontaneously diabetic animals [6][7][8].
immediate precursor for UDP-sugar formation (Fig. 1) , is expanded in the renal cortex of rats 48 hr after the induction of diabetes [9, 14] . However, it is questionable if this increase in UTP pool size would enhance the formation of UDP derivatives because their synthesis in vitro is strictly regulated by feedback inhibition of UDPG-pyrophosphorylase (EC 2.7.7.9) and glucosamine synthetase (EC 2.6.1.16) by UDP-glucose (UDPG) and UDP-N-acetylglucosamine (UDPAG), respectively [15, 16] (Fig. 1) .
The purpose of the study was to assess the relationship of the UTP pool size to the rates of formation and pool sizes of UDPsugars and UDP-amino sugars in the renal cortex of rats shortly after the onset of streptozotocin-induced diabetes. In addition, the effects of exogenously induced alterations in the UTP pool on the pools of its UDP derivatives were investigated.
Methods
Male Fisher rats, weighing 160 to 200 g, were used. Following insertion of permanent cannulae into the left femoral vein [9] , the rats recovered from surgery for 14 days before experiments were carried out. The animals had free access to food and water throughout the duration of the studies. Diabetes was induced by the i.v. injection of 50 mg/kg streptozotocin (U-9889, a gift from the Upjohn Co., Kalamazoo, Michigan) dissolved in 0.15 M sodium chloride acidified to pH 4.0 with 0.1 M citrate buffer. A control group of animals injected with the same volume of acidified 0.15 M sodium chloride was included in each experiment. Eighty control and 70 diabetic rats were used.
A continuous infusion of 0.15 M sodium chloride at a rate of 3 Id/mm was started 24 hr before the termination of the experiments. In one experiment, in order to expand the endogenous UTP pool, sodium orotate was infused [14] at a rate of 1 p.mol/ hr in groups of control and diabetic rats. In a separate experiment, in order to deplete the UTP pool, adenine hydrochloride was infused at a rate of 4 mol/hr in a group of control animals. Previous experiments have demonstrated that orotate or adenine given at the above rates does not result in renal damage from intratubular crystallization [14] . To study the incorporation of pyrimidine precursors into nucleotides, radiolabeled orotate was added to all infusates during the final 2 hr of infusion period. In rats given sodium orotate, radiolabeled precursors were not used. Each animal received 60 Ci of [5-3H]orotic acid (sp act 20 Ci/mmole) and a total of 0.1 mo1e of orotate. In previous studies in which this method was applied, linear increases in UTP and RNA specific radioactivities were demonstrated in the diabetic and control renal cortex over the 2-hr infusion of radiolabeled orotate [9] .
All experiments were terminated 48 hr after the administration of streptozotocin. At the end of the infusion period, the left kidneys were exteriorized through a lumbar incision and a sample of renal cortex was obtained with immediate freezing in liquid nitrogen [9] . Blood samples were obtained by cardiac puncture, and plasma was separated for the measurement of glucose by the glucose oxidase method. In all streptozotocininjected rats plasma glucose concentrations were greater than 300 mg/dl. Medullary fragments included in the frozen cortical samples were scraped from the cortex under liquid nitrogen.
Samples weighing 200 to 300 mg were pulverized in a precooled stainless steel mortar and placed in 0.2 M perchloric acid at 2° C. As an internal standard 0.25 Ci of [2-'4C]UTP was added to each sample for assessment of UTP recovery. The tissue was homogenized in 0.2 M perchloric acid; the acid-soluble fraction was neutralized immediately with I M potassium hydroxide and was lyophilized for later chromatographic analysis [9] .
RNA and DNA were extracted from the acid-insoluble fraction and were quantified by their pentose content as determined by the orcinol and diphenylamine reactions respectively [9] .
With these methods 1 p.g of yeast RNA (type I, Sigma Chemical Co., St. Louis, Missouri) is equivalent to 0.6 pg of ribose, and 1 ig of calf thymus DNA (type I, Sigma) is equivalent to 0.13 i.g of deoxyribose.
High-pressure liquid chromatographic analyses. Lyophilized samples were resuspended in 0.15 to 0.2 ml of distilled water and centrifuged at 107,000 x g for 30 mm. UTP was quantitated in 22-sl samples of the supernatant by anion-exchange chromatography as described previously [9] . In each separate experiment, equal portions of the remaining supernatants of the nucleotide extracts derived from the left renal cortices of three to 11 (mean of seven) rats in control and experimental groups were pooled for UDP-sugar analysis.
Quantitative chromatographic analysis of UDP-sugars was carried out by a method combining reversed-phase and anionexchange separation modes using 4.6 x 25 cm columns of Zorbax-NH2 (DuPont Co., Wilmington, Delaware). Analyses were performed at room temperature in a Beckman 332 liquid chromatograph system (Beckman Instruments Inc., Fullerton, California). Samples were eluted at a flow of 1 mllmin with a concave gradient formed by (1) an initial buffer consisting of 0.08 M potassium phosphate, pH 2.8 containing 35% acetonitrile and (2) a final buffer consisting of 0.8 M KH2PO4, pH 3.6. To ensure a steady baseline, an identical chromatographic column was connected to the reference side of the absorbance detector; eluant was forced through it at the same flow rate as on the sample side. Peaks were detected by simultaneous monitoring at 254 and 280 nm and their areas quantitated using a Waters' Data Module electronic integrator (Waters Associates Inc., Milford, Massachusetts). With this method, UDP, UDPG, UDP-glucuronic acid (UDPGA), UDPAG, and UDP-N-acetyl galactosamine (UDPA-GAL) were separated in 70 mm. UDPgalactose (UDP-GAL), UDP-mannose, and UDP-xylose eluted as a single peak and are referred to as UDP-GAL in this study. The differences in the chromatographic quantitation of UDP derivatives in duplicate analyses varied between 3 and 10% for UDPAG and UDPGA, respectively. Peaks were identified according to: (1) retention times of purified standards, (2) ratio of absorbancy at 254 and 280 nm, (3) co-chromatography of radiolabeled UDP-sugars. Column effluents were collected in 0.2 ml fractions for determination of 3H and '4C radioactivity. The resolution of the UDP-sugars did not vary appreciably between chromatographic columns but was influenced by the number of tests done with each column. The quantitation of UDPG exhibited interference in some analyses by incomplete separation from an unidentified compound which was not a uracil derivative and did not contain radioactivity. This difficulty was resolved by combining specific enzymatic methods [17] for the measurement of UDP-sugars with the original chromatographic methods described previously. Quantitative enzymatic oxidation of UDPG to UDPGA was carried out in 20 to 50 l of the final sample prepared for chromatographic analysis. Samples were incubated for 15 mm with 80 to 200 mU of bovine liver UDPG dehydrogenase (EC 1.1.1.22, type III, Sigma) in an assay system containing 3 m nicotinamide adenine dinucleotide (NAD) and 0.5 M glycine buffer, pH 8.7 at room temperature [18] . The same volume of the final nucleotide extract was incubated as a control sample without enzyme under identical conditions. A 29-pJ portion of the final enzymatic or control incubation mixtures was used for chromatographic quantitation. The amount of UDPG in the sample was estimated as the increase in UDPGA after enzymatic oxidation of UDPG. When [glucose-'4C(U)]UDPG (sp act 334 mCilmmole) was used as internal standard, 92 to 102% of the radioactivity added was recovered as [14C]UDPGA. The preparation of UDPG dehydrogenase used did not contain UDPG pyrophosphorylase (EC 5.1.3.2) activity as demonstrated by the lack of incorporation of '4C from the internal standard ['4C]UTP into UDPG or UDPGA in tissue extracts in which UTP and glucose 1-phosphate were present.
Standards and radiolabeled compounds. All standards were obtained from Sigma Chemical Co., St. Louis, Missouri. Nude-
Sialic Acid otide standards for chromatographic analyses were prepared as mixtures of purified nucleotides in proportions similar to those found in the rat renal cortex. Radiolabeled compounds were obtained from New England Nuclear Corp. (Boston, Massachusetts). The radiochemical purity of all nucleotide standards used was tested by high-pressure liquid chromatography at the end of each experiment. The purity of
Presentation of data and statistical analysis. RNA and DNA were expressed as their pentose equivalents. Values for nucleotide content were corrected according to the final UTP recovery for extraction and analytical methods. This recovery varied between 69 and 94%. Incorporation values are presented as fractions of the dpm infused/200 g of body wt, correcting for the small changes in mean weight between rats in different experimental groups. Results are expressed per unit DNA because:
(1) It is the reference of choice to evaluate changes in tissue composition during rapid growth [19] , (2) is the only renal component that remains constant during early diabetic renal growth [20] , and (3) is equivalent to the expression of results per cell in the renal cortex because of the uniploidy of its cells. To assess tissue concentration of nucleotides, the results are expressed per unit of frozen tissue weight also.
All results are presented as means SEM withthe number of observations in parenthesis. The statistical significance of the differences was determined by Student's t test for nonpaired variables when groups of control and experimental animals from one experiment were compared. When the mean values to be compared originated from pairs of control and experimental samples in separate experiments, the Student's t test for paired variables was used.
Results
Effects of short-term diabetes on the renal cortical cell content of UDP-sugars and UDP-amino sugars. In normal renal cortex the pool of UTP was appreciably larger than any of the pools of the UDP-sugars or UDP-amino sugars which are derived from it (Table 1) . Further, the size of the total UDPamino sugar pool was 50% greater than that of the total UDPsugar pool. UDPAG was the most abundant single compound, having the largest pool size (Table 1 ) and a tissue concentration of 168 11 nmole/g. The concentration of UDPG was 117 11 nmole/g with a cellular pool which was about two-thirds the size of the UDPAG pool (Table 1 ).
In the diabetic renal cortex, 48 hr after the injection of streptozotocin, there were marked changes in the contents of uracil nucleotides. Both the UTP pool and the pools of its metabolic derivatives were consistently increased in each of the seven experiments (Table 1) , except for the UDP-GAL pool in which no change was demonstrated. The alteration in nucleotide content was not of the same magnitude in all pools because there was a greater increase in the size of the UDP-sugar and UDP-amino sugar pools than in the UTP pool (Table 1 ). The magnitude of the change in the pools of UDP-amino sugars was greater than in the pools of UDP-sugars. The size of the total UDP-amino sugar pool was then about 100% greater than the total UDP-sugar pool in the diabetic cortex. The greatest change was found in the size of the pool and in tissue concentration of UDPAG which increased by 68 and 47%, respectively, (concentration in diabetic cortex, 248 9 nmole/g). There were also significant increases in the pools of UDPG and of UDPGA, (Table 1) which is the immediate product of UDPG oxidation ( Fig. 1 ). Effects of short-term diabetes on the incorporation ofpyrimidine precursors into renal cortical UDP-sugars and UDPamino sugars. A continuous 2-hr infusion of small amounts of [3H]orotate resulted in substantial labeling of UTP and all UDP derivatives. In the control animals the greatest incorporation of precursor was in UTP. The specific radioactivity of the UTP pool was 50% greater than in UDPAG and UDPG ( Table 2 ). The incorporation of precursor into UDP-sugars and UDP-amino sugars was similar. However, the resulting specific radioactivity of the UDPG pool was significantly greater than the UDPAG pool (P < 0.025).
In diabetic rats there was a significant increase in the incorporation of precursor into UTP. In addition [3H]orotate incorporation into UDP-sugars and UDP-amino sugars was increased also, except for UDP-GAL where the difference was not significant (Table 2 ). This increase in precursor incorporation was not uniform in all pools. The incorporation into UDPAG was 74% greater than in controls while the corresponding increases in UDPG and UDPGA were 41 and 77%, respectively. The augmented incorporation into UDP derivatives in the diabetic cortex was not associated with substantial increases in the specific radioactivity of the pools measured (Table 2) .
However, the specific radioactivity of the UTP pool increased by 25% which was significant. To rule out the possibility that this increase in UTP specific radioactivity was the primary cause for the greater incorporation of labeled precursor into the UDPAG and UDPG pools, we factored the total radioactivity found in these pools by the UTP specific radioactivity. The factoring resulted in corrected incorporation values which were still greater in diabetic animals ( Table 2) .
Effects of the administration of orotate or adenine on the renal cortical pools of UDP-sugars and UDP-amino sugars.
The continuous 24-hr infusion of orotate resulted in significant increases in the renal cortical pool of UTP in both control [440 12(10) vs. 645 26(10) nmole/mg DNA, P < 0.001] and diabetic animals [502 12 (9) vs. 797 36(10) nmole/mg DNA, P < 0.001] although the increase was greater in the latter (control 46%, diabetic 59%). In this experiment the expansion of the UTP pooi was associated with appreciable increases in the content of UDPAG and UDPG as measured in a pooled sample of control or diabetic animals (Fig. 2) . However, this increase was of lesser magnitude in diabetics than in controls although the final UDPAG and UDPG pools in the diabetic were greater. The pool of UDPAG which was already expanded in nontreated diabetics increased 12% after orotate infusion while the corresponding increase for controls was 29%. Similarly, the expanded pool of UDPG in the diabetic cortex was 21% greater after orotate infusion; the normal pool of the control cortex increased 31% after the same treatment (Fig. 2) . The pools of UDPA-GAL and UDPGA were minimally altered following orotate administration.
In a separate experiment, the 24-hr infusion of adenine to control animals resulted in a significant depletion of the UTP pool [513 11 (20) shown to occur concomitant with the loss of UTP (Fig. 3 ). In addition, the amount of [3H]orotate incorporated into UDPG decreased from 3.2% in control to 0.88% in adenine treated animals. Similarly, the incorporation into UDPAG also decreased from 3.1 to 0.66%.
When the sizes of the cortical UTP and UDPG pools obtained in each individual experiment were correlated, a significant, positive correlation was found (Fig. 4 ).
Discussion
The development of the new chromatographic technique described in this paper has permitted metabolic studies of the more abundant UDP compounds present in the renal cortex. Using this technique, the measured renal cortical concentralions of UDPG is similar to values previously described for the whole kidney [18] .
The present studies demonstrate that the metabolic changes in pyrimidine nucleotides described previously in the renal cortex of the diabetic kidney are not limited to UTP and its precursors (Fig. 1 ). There is also expansion of the UDP-sugar and UDP-amino sugar pools which is greater than that of the UTP pool itself. Previous studies have shown that the rapid increase in the renal cortical content of UTP and in the synthesis of pyrimidine nucleotides in the diabetic kidney can be prevented by insulin replacement [9] . It is likely, therefore, that the metabolic alterations in UDP derivatives are also related to insulin deficiency.
The expansions of the UDPAG, UDPA-GAL, UDPG, and UDPGA pools in diabetes are probably due to increased synthesis rather than to decreased utilization. This possibility is suggested by the marked increase in the incorporation of radiolabeled orotate into each individual pool without alteration in the specific radioactivity of these. Further, the increased incorporation of radioactivity into UDPAG and UDPG is not offset by utilizing the specific radioactivity of UTP for the correction of the results. Consequently, the greater labeling of UDP-sugars and UDP-amino sugars cannot be explained by the increased amounts of label present in the UTP precursor pool. The results of this study demonstrate the dependence of the formation of renal cortical UDPAG and IJDPG on the size of their immediate UTP precursor pooi. Expansion of the UTP pool by providing exogenous orotate as substrate for pyrimidine synthesis de novo [14] is followed by increases in the UDPAG and UDPG pools. The change is of lesser magnitude in diabetics, probably because in the diabetic cortex the pools are already expanded markedly. Limiting the bioavailability of phosphorybosylpyrophosphate for pyrimidine synthesis by the administration of adenine [14, 21] , thus depleting the UTP pool, is also associated with decrement of the UDPGA and UDPG pools. Analysis of the data obtained in this study shows that cortical UDPG contents between 200 and 500 nmol/mg DNA correlate directly with the size of the UTP pool. The importance of the size of the UTP pool as a determinant of the synthesis of UDP-sugars and UDP-amino sugars in vivo has been demonstrated also in the liver of the rat in vivo [22, 23] and in vitro [24, 25]. The reasons for the absence of feedback control of the synthesis of UDP-sugars and UDP-amino sugars by the expanded UDPG and UDPAG pools in orotate-treated animals is unclear. Although it has been demonstrated that the activity of specific enzymes is rate limiting in the synthesis of these compounds in vitro [15, 16] , it is doubtful whether the same occurs in vivo. One possibility is that variations in the tissue concentrations of secondary inhibitors and activators such as AMP and UTP [16, 26] may be determinants of enzymatic activity in vivo. Analysis of the metabolic changes in individual UDP derivatives demonstrates that in the diabetic cortex, UDPAG presents the greatest pool expansion and UDPAG and UDPGA the greatest increase in precursor incorporation. There is, therefore, an abundance of substrates for the synthesis of glycosaminoglycans. The concentration of heparan sulfates, the major glycosaminoglycans in the mammalian renal cortex [27] , has been found to be increased in kidneys of diabetic patients [28] .
Further, heparan sulfate is an important constituent of the noncollagenous portion of the glomerular BM [29] [30] [31] and glycosaminoglycans are actively synthetized by glomerular cells in vitro [32] and deposited as part of BM material [33] . It is possible that the increased bioavailability of its precursors and the abnormal synthesis of glycosaminoglycans play an important role in the deposition of BM material in the diabetic kidney.
The changes in UDPG pooi size, although smaller than for UDPAG, and precursor incorporation into UDPG could have metabolic significance. The UDPG pool has the fastest turnover rate of all the renal cortical UDP derivatives as suggested by its greater specific radioactivity after the infusion of [3H]orotate.
In the renal cortex, the bioavailability of UDPG appears to affect glycogen synthesis because chronic orotate administration to rats is associated with increased content of glycogen [34] .
The extent to which the bioavailability of substrate modifies the composition or net synthesis and deposition of structural glycoproteins is not known. In the rat liver, depletion of UDPAG is associated with decreased glycoprotein synthesis [22, 35, 36] , but the expansion of the pools of UDP-sugars and UDP-amino sugars during 2 days of orotate administration does not alter the rate of incorporation of glucosamine from UDPamino sugars into plasma glycoproteins [22] . The administration of orotate over a 6-month period results in thickening of the glomerular BM in normal rat kidneys and in augmentation of the glomerular BM thickening of diabetic rats [34] . Using the values obtained in the present study and published figures for intracellular water in the renal cortex [37, 38] , the calculated concentra- purified enzyme preparation [39] . Thus, it could be assumed that increases in UDPG would not enhance enzymatic activity. However, it is difficult to predict enzyme action in vivo because the activity of glycosyltransferases, as in the case with the enzymes involved in UDP-sugar synthesis, is modified by specific nucleotides [40, 41] which are likely to exert a regulatory role in the intact animal. It is not know what fraction of the UDP derivatives formed in excess in the diabetic kidney is utilized for the glycosylation of proteins. Part of the normal metabolism of UDP-sugars and UDP-amino sugars consists of hydrolytic breakdown by the action of specific pyrophosphatases [42, 43] . Their activities are modulated independently, in turn, by the tissue concentrations of specific nucleotides [441. However, there is no information available on the activity of nucleotide pyrophosphatases in the kidney.
The effects of the bioavailability of precursors on the synthesis of glycoproteins are exerted obviously in cellular compartments in which precursors are accessible to the specific glycosyltransferases. This study deals only with the total tissue content of UDP derivatives; comment on cellular compartmentation of these pools would be speculative. The UTP pool seems to be distributed in at least two compartments in cortical cells, one serving as an RNA precursor and the other as a UDP-sugar precursor [45] . Similarly, measurements of total cortical content of UDP derivatives do not take into account the structural heterogeneity of the entire tissue. However, it is likely that the observed alterations in the metabolism of UTP and UDP derivatives in the whole renal cortex also occur in the glomeru-Ii. Previous studies have shown rapid increases in the glomerular synthesis of pyrimidine nucleotides and in the content of RNA after the induction of diabetes similar to the metabolic changes described in the whole renal cortex [46] .
It is theorized that an increase in the bioavailability of renal UDP-sugars and UDP-amino sugars is necessary for the exag- of control and over a 48-hr period in diabetic rats. In control rats these pools measured: UDPG, 256 23; UDP-GAL, 75 14; UDPGA, 147 16; UDPAG, 367 23; UDPG-GAL, 131 13 nmoles/mg DNA. In diabetic rats, except for UDP-GAL, all pools were increased 41 to 68%. The incorporation of radiolabeled orotate was increased in all pools, except UDP-GAL, in diabetic rats by 41 to 77% compared to control rats. The incorporation into UDPG and UDPAG was increased even after correction for the specific radioactivity of their immediate precursor, uridine 5'-triphosphate (UTP). Expansion of the UTP pool after orotate infusion was associated with an increase in the size of the UDPG and UDPAG pools in both control and diabetic rats. Depletion of the UTP pool after adenine infusion in controls was associated with a decrease in all pools. This study demonstrates that after the induction of diabetes there is a rapid increase in the bioavailability of substrates utilized in the synthesis of glycoproteins and glycosaminoglycans. It is theorized that this increase is necessary for the augmented synthesis of basement membrane-like material in the diabetic kidney.
